Klatte J Michael, Selvarangan Rangaraj, Jackson Mary Anne, Myers Angela L
Department of Pediatrics, Baystate Medical Center and Tufts University School of Medicine, Springfield, Massachusetts; and
Children's Mercy Hospital and University of Missouri-Kansas City School of Medicine, Kansas City, Missouri.
Hosp Pediatr. 2016 Jan;6(1):9-14. doi: 10.1542/hpeds.2015-0116. Epub 2015 Jan 1.
Study objectives included addressing overuse of Clostridium difficile laboratory testing by decreasing submission rates of nondiarrheal stool specimens and specimens from children ≤12 months of age and determining resultant patient and laboratory cost savings associated with decreased testing.
A multifaceted initiative was developed, and components included multiple provider education methods, computerized order entry modifications, and automatic declination from laboratory on testing stool specimens of nondiarrheal consistency and from children ≤12 months old. A run chart, demonstrating numbers of nondiarrheal plus infant stool specimens submitted over time, was developed to analyze the initiative's impact on clinicians' test-ordering practices. A p-chart was generated to evaluate the percentage of these submitted specimens tested biweekly over a 12-month period. Cost savings for patients and the laboratory were assessed at the study period's conclusion.
Run chart analysis revealed an initial shift after the interventions, suggesting a temporary decrease in testing submission; however, no sustained differences in numbers of specimens submitted biweekly were observed over time. On the p-chart, the mean percentage of specimens tested before the intervention was 100%. After the intervention, the average percentage of specimens tested dropped to 53.8%. Resultant laboratory cost savings totaled nearly $3600, and patient savings on testing charges were ∼$32 000.
Automatic laboratory declination of nondiarrheal stools submitted for CDI testing resulted in a sustained decrease in the number of specimens tested, resulting in significant laboratory and patient cost savings. Despite multiple educational efforts, no sustained changes in physician ordering practices were observed.
研究目标包括通过降低非腹泻性粪便标本以及12个月及以下儿童标本的送检率,来解决艰难梭菌实验室检测过度使用的问题,并确定与检测减少相关的患者和实验室成本节约情况。
制定了一项多方面的举措,其组成部分包括多种提供者教育方法、计算机化医嘱录入修改,以及实验室自动拒绝检测非腹泻性状的粪便标本和12个月及以下儿童的粪便标本。绘制了一张运行图,展示随时间推移提交的非腹泻性加婴儿粪便标本数量,以分析该举措对临床医生检测医嘱开具行为的影响。生成了一张p图,以评估在12个月期间每两周对这些提交标本进行检测的百分比。在研究期结束时评估了患者和实验室的成本节约情况。
运行图分析显示干预后出现了初始变化,表明检测送检暂时减少;然而,随着时间推移,未观察到每两周提交标本数量的持续差异。在p图上,干预前检测标本的平均百分比为100%。干预后,检测标本的平均百分比降至53.8%。实验室成本节约总计近3600美元,患者检测费用节约约32000美元。
实验室自动拒绝提交用于艰难梭菌感染(CDI)检测的非腹泻性粪便,导致检测标本数量持续减少,从而为实验室和患者节省了大量成本。尽管进行了多项教育努力,但未观察到医生医嘱开具行为的持续变化。